NCT00030641 2014-01-06
Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2/3 Unknown
Clinical Trials
3 trialsNCT00070343 2014-01-06
Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
National Cancer Institute (NCI)
Phase NA Unknown
NCT00409383 2011-11-07
Abraxane and Temodar Plus Genasense in Advanced Melanoma
Genta Incorporated
Phase 1 Unknown